Newsfiscal.ai
MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 at Precision Liver Symposium 2026
· Published
Article summary
MetaVia Inc. announced it will present Phase 1 clinical trial data for its lead pipeline candidate, DA-1726, in an oral presentation at the upcoming Precision Liver Symposium 2026.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…